semaglutide side effects on eyes Ozempic Blindness Lawsuit [2026 Update] Wegovy linked to rare “eye

The injectable forms were approved first, with Ozempic receiving FDA approval in 2017 for type 2 diabetes and for reducing major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease

If youre interested in exploring tirzepatide as a potential solution for your weight loss journey, reach out to our team for personalized guidance and support

The focus should be on providing the body with what it needs to be healthy, rather than eliminating foods like carbohydrates

By binding to GLP-1 receptors in the hypothalamus, they reduce appetite and promote satiety, leading to significant weight reduction in clinical trialswith newer agents achieving approximately 15% weight loss in obesity without diabetes (semaglutide) and up to 21% (tirzepatide), with somewhat lower reductions typically seen in patients with type 2 diabetes